Moderna, Merck say mRNA treatment cuts risk of melanoma recurrence, spread

Aug 20, 2026 · 0:04:42

Listen to Episode

✨ AI Summary

Moderna and Merck's mRNA vaccine cuts melanoma risk.
First positive final-stage trial for mRNA cancer therapy.
Poh Kok Ing explains the new skin cancer treatment.

More from CNA

Working with a recruiter? Ask these questions before saying yes | Work It

Aug 24, 2026 · 0:34:04

National Day Rally 2026: New western island, more land reclamation for future needs among plans

Aug 23, 2026 · 0:03:59

National Day Rally 2026: S'pore to handle gains, risks of tech change on its own terms, says PM Wong

Aug 23, 2026 · 0:03:59

NDR 2026 announcements in 3 minutes

Aug 23, 2026 · 0:02:59

View all episodes →